Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,722.00    -34.00 (-0.71%)
Bid:
4,726.00
Ask:
4,732.00
Spread: 6.00 (0.127%)
Market Cap: £2.20b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Pre-close trading update

17 Dec 2009 07:00

RNS Number : 2597E
Morgan Sindall PLC
17 December 2009
Β 

ο»Ώ

17 Dec 2009

Morgan Sindall plc

Morgan Sindall plc, the construction and regeneration group, provides the following period end trading update in advance of the announcement of its preliminary results for the year ended 31 December 2009, expected to be in late February 2010.Β 

Trading

As previously announced in our Interim Management Statement on 10 November, Morgan Sindall remains on track to achieve its expectations for the current year, despite the challenging market conditions in which it is operating.Β 

Fit Out is performing strongly in tough market conditions with margins remaining robust and it continues to see a recovery in the level of tendering activity.

Construction is still experiencing healthy demand from the public sector and, in particular, is currently advancing two major projects at preferred bidder stage, Tayside Mental Health (Β£100m) and Hull BSF (Β£200m). We expect to achieve financial close on these projects during the first quarter of 2010. There remains considerable uncertainty over future public spending commitments.

Infrastructure Services continues to perform well in reasonably buoyant market conditions and the division continues to progress a number of major opportunities. Although the bidding processes are proving more protracted than initially anticipated, we continue to await the outcome of preferred bidder decisions on a number of contracts.Β 

Affordable Housing is still seeing a reasonable pipeline of refurbishment and new build social housing opportunities. This is complemented by improvements in demand for open market housing with sales continuing to improve.

Urban Regeneration's market remains subdued although we expect recovery in market conditions in the longer term.

The Investments division is seeing a strong pipeline of opportunities and we expect that it will increase its level of bidding activity in 2010, thereby taking advantage of the Group's increasing ability to deliver larger and more complex projects since the acquisition made in 2007.

Outlook

The Group's forward order book has reduced from Β£3.6bn to Β£3.2bn since 30 June 2009. However, this forward order book is supplemented by over Β£900m of projects at preferred bidder stage, all of which have been awarded during the second half of this year.Β 

We remain mindful of the challenges facing the sector in the longer term and continue to shape our business accordingly. Each of our divisions continues to particularly focus on cash management, cost reduction and supply chain improvements, as well as responding to market growth opportunities where they present themselves.

In summary, Morgan Sindall is on track to meet our expectations for 2009 and is well placed to meet the challenges and opportunities in 2010.

Enquiries:

MorganΒ SindallΒ plc

Tel:Β 020Β 7307Β 9200

PaulΒ Smith,Β ChiefΒ Executive

DavidΒ Mulligan,Β FinanceΒ Director

BlytheΒ WeighΒ Communications

Tel:Β 020Β 7138Β 3204Β 

TimΒ Blythe

Mob:Β 07816Β 924626

PaulΒ Weigh

Mob:Β 07989Β 129658Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTCKAKBOBDDNBD
Date   Source Headline
20th Oct 20239:05 amRNSBlock listing Interim Review
10th Oct 202311:44 amRNSAdditional Listing
12th Sep 20233:12 pmRNSHolding(s) in Company
4th Sep 202312:51 pmRNSAGM Voting Update
1st Sep 20239:45 amRNSTotal Voting Rights
22nd Aug 20233:56 pmRNSAdditional Listing
10th Aug 202311:50 amRNSDirector/PDMR Shareholding
10th Aug 202311:45 amRNSDirector/PDMR Shareholding
2nd Aug 20236:30 pmRNSResults for the Half Year (HY) Ended 30 June 2023
1st Aug 202311:13 amRNSTotal Voting Rights
10th Jul 20237:00 amRNSNotice of Half Year Results
3rd Jul 202310:37 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSTrading Update
14th Jun 20232:10 pmRNSAdditional Listing
14th Jun 20239:13 amRNSHolding(s) in Company
12th Jun 20233:50 pmRNSHolding(s) in Company
1st Jun 20239:16 amRNSTotal Voting Rights
31st May 20234:10 pmRNSHolding(s) in Company
10th May 202311:19 amRNSAdditional Listing
5th May 20232:38 pmRNSHolding(s) in Company
4th May 202312:44 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
20th Apr 202310:24 amRNSBlock listing Interim Review
23rd Mar 20231:51 pmRNSAnnual Financial Report
21st Mar 20234:24 pmRNSAdditional Listing
16th Mar 20233:34 pmRNSDirector/PDMR Shareholding
16th Mar 20231:52 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSUK Government Self Remediation Contract
13th Mar 20232:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:58 amRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
2nd Mar 20234:42 pmRNSDirector/PDMR Shareholding
2nd Mar 20234:41 pmRNSDirector/PDMR Shareholding
1st Mar 202311:28 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSFinal Results
6th Feb 20237:00 amRNSNotice of Full Year Results
1st Feb 20231:04 pmRNSTotal Voting Rights
25th Jan 20232:59 pmRNSHolding(s) in Company
3rd Jan 20231:56 pmRNSTotal Voting Rights
12th Dec 20228:25 amRNSHolding(s) in Company
5th Dec 20223:37 pmRNSHolding(s) in Company
2nd Dec 20229:06 amRNSTotal Voting Rights
7th Nov 20224:08 pmRNSAGM Voting Update
2nd Nov 20227:00 amRNSTrading Update
1st Nov 20221:49 pmRNSTotal Voting Rights
20th Oct 202211:00 amRNSBlock listing Interim Review
18th Oct 20221:16 pmRNSAdditional Listing
3rd Oct 20221:51 pmRNSTotal Voting Rights
13th Sep 20223:27 pmRNSAdditional Listing
1st Sep 202210:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.